→ GSK has made a key hire for a crucial part of its business, appointing Sanjay Gurunathan as global head of vaccines and infectious disease R&D. Over the course of 25 years with Sanofi, Gurunathan ...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.